Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
For acute myeloid leukaemia, genetic testing is often worth the wait
New tailored therapies offer exciting prospects for treating acute myeloid leukaemia (AML), but taking advantage…
How does cancer develop resistance to treatment?
Cancer cells can turn on error-prone DNA copy pathways to adapt to cancer treatment, a…
New Evidence of Dangers of High-Fat Diet on Pre-cancerous Conditions
New QIMR Berghofer research indicates that a high-fat diet over a long period of time…
How Australians Die: cause #2 – cancers
By Terry Slevin, Cancer Council Australia and Andrew Redfern, University of Western Australia. Described as “The Emperor of All Maladies”…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.